import Link from "next/link";
import type { Metadata } from "next";

export const metadata: Metadata = {
  title: "India IVF Regulations & Fertility Law 2026 | FertilityCareHub",
  description:
    "Structured analysis of IVF regulations, donor laws, surrogacy policy, and fertility access rules in India. Updated regulatory insights for intended parents.",
  alternates: {
    canonical: "https://fertilitycarehub.com/countries/india",
  },
  openGraph: {
    title: "India IVF Regulations & Fertility Law 2026",
    description:
      "In-depth fertility law analysis covering IVF, donor gametes, surrogacy, and access regulations in India.",
    url: "https://fertilitycarehub.com/countries/india",
    siteName: "FertilityCareHub",
    type: "article",
  },
};
export default function IndiaPage() {
  return (
    <main className="min-h-screen bg-[#F5F1E8] text-[#1A1A1A]">
      {/* Top utility bar */}
      <div className="max-w-6xl mx-auto px-6 pt-10">
        <div className="flex items-center justify-between">
          <Link
            href="/countries"
            className="text-sm tracking-wide text-[#6A6256] hover:text-[#1A1A1A]"
          >
            ← Back to countries
          </Link>

          <Link
            href="/consultation"
            className="inline-flex items-center justify-center rounded-full border border-[#B89B5E] px-5 py-2 text-sm tracking-wide text-[#1A1A1A] hover:bg-[#F0E7D6]"
          >
            Review India Strategy Privately
          </Link>
        </div>
      </div>

      {/* Hero */}
      <section className="max-w-6xl mx-auto px-6 pt-14 pb-10">
        <div className="text-center">
          <div className="text-xs tracking-[0.28em] text-[#6A6256]">
            STRATEGIC ADVISORY DOSSIER
          </div>

          <h1 className="mt-5 text-5xl md:text-6xl leading-tight font-medium">
            India
          </h1>

          <p className="mt-6 max-w-3xl mx-auto text-lg leading-relaxed text-[#2A2A2A]">
            India is a cost-differentiated, high-volume fertility market where outcomes depend
            heavily on <strong>clinic selection</strong>, lab discipline, and coordination quality.
            The strategic advantage can be strong capability at a materially lower cost structure.
            The tradeoff is variability across providers — execution must be curated, not crowdsourced.
            This dossier outlines when India is the right strategic fit, when it isn’t, and how to
            evaluate it with precision.
          </p>
        </div>
      </section>

      {/* Two-column decision block */}
      <section className="max-w-6xl mx-auto px-6 pb-10">
        <div className="grid md:grid-cols-2 gap-6">
          <div className="rounded-2xl border border-[#E5DDC8] bg-[#FAF7F1] p-8">
            <h2 className="text-xl font-medium">When India is the right choice</h2>
            <ul className="mt-5 space-y-3 text-[15px] leading-relaxed text-[#2A2A2A] list-disc pl-5">
              <li>
                You want a <strong>strong cost structure</strong> while still accessing advanced care.
              </li>
              <li>
                You are willing to work with a curated shortlist rather than browsing hundreds of providers.
              </li>
              <li>
                You want a market with high clinical volume and established patient pathways.
              </li>
              <li>
                You can operate with structured coordination (documentation, timing, travel windows).
              </li>
              <li>
                You value execution planning and clear written protocols.
              </li>
            </ul>
          </div>

          <div className="rounded-2xl border border-[#E5DDC8] bg-[#FAF7F1] p-8">
            <h2 className="text-xl font-medium">When it’s not</h2>
            <ul className="mt-5 space-y-3 text-[15px] leading-relaxed text-[#2A2A2A] list-disc pl-5">
              <li>
                You want a highly standardized national system with low provider variability.
              </li>
              <li>
                You need a pathway requiring frameworks that may be restricted for international patients.
              </li>
              <li>
                You are unwilling to do structured planning and coordination.
              </li>
              <li>
                You want a “hands-off” approach without due diligence and verification.
              </li>
            </ul>
          </div>
        </div>
      </section>

      {/* Framework */}
      <section className="max-w-6xl mx-auto px-6 pb-12">
        <div className="rounded-2xl border border-[#E5DDC8] bg-[#FAF7F1] p-8">
          <h2 className="text-2xl font-medium">Advisor framework: how to evaluate India</h2>

          <div className="mt-6 grid md:grid-cols-3 gap-6">
            <div>
              <div className="text-xs tracking-[0.25em] text-[#6A6256]">VARIABILITY</div>
              <p className="mt-3 text-[15px] leading-relaxed text-[#2A2A2A]">
                India’s advantage is depth and cost structure. The risk is variability.
                Strategy is about selecting the right provider model — not selecting a country.
              </p>
            </div>

            <div>
              <div className="text-xs tracking-[0.25em] text-[#6A6256]">LAB DISCIPLINE</div>
              <p className="mt-3 text-[15px] leading-relaxed text-[#2A2A2A]">
                Embryology capability and lab consistency drive outcomes. We prioritize clinics
                with stable teams, transparent add-ons, and rigorous protocol clarity.
              </p>
            </div>

            <div>
              <div className="text-xs tracking-[0.25em] text-[#6A6256]">COORDINATION</div>
              <p className="mt-3 text-[15px] leading-relaxed text-[#2A2A2A]">
                Successful execution requires structured coordination: records readiness,
                monitoring cadence, travel windows, and clear follow-up after return.
              </p>
            </div>
          </div>
        </div>
      </section>

      {/* Core sections */}
      <section className="max-w-6xl mx-auto px-6 pb-12">
        <div className="grid md:grid-cols-2 gap-6">
          <div className="rounded-2xl border border-[#E5DDC8] bg-[#FAF7F1] p-8">
            <h3 className="text-xl font-medium">Clinic selection approach</h3>
            <ul className="mt-5 space-y-3 text-[15px] leading-relaxed text-[#2A2A2A] list-disc pl-5">
              <li>
                We shortlist selectively (typically 4–5), not exhaustively.
              </li>
              <li>
                We confirm lab capability, embryology staffing stability, and written planning.
              </li>
              <li>
                We validate inclusions vs add-ons to prevent “low headline / high final bill.”
              </li>
              <li>
                We prioritize international patient coordination and clear response standards.
              </li>
            </ul>
          </div>

          <div className="rounded-2xl border border-[#E5DDC8] bg-[#FAF7F1] p-8">
            <h3 className="text-xl font-medium">Cost structure (strategic view)</h3>
            <ul className="mt-5 space-y-3 text-[15px] leading-relaxed text-[#2A2A2A] list-disc pl-5">
              <li>
                India can offer materially lower costs, but price is only valuable if execution quality is protected.
              </li>
              <li>
                We model total pathway cost: cycle + lab add-ons + meds + monitoring + logistics + storage.
              </li>
              <li>
                We provide bounded ranges in advisory; we avoid publishing numbers without verification.
              </li>
            </ul>
            <p className="mt-5 text-sm text-[#6A6256]">
              Note: “value” is outcome + predictability, not the cheapest headline.
            </p>
          </div>

          <div className="rounded-2xl border border-[#E5DDC8] bg-[#FAF7F1] p-8">
            <h3 className="text-xl font-medium">Logistics and travel (including accommodation)</h3>
            <ul className="mt-5 space-y-3 text-[15px] leading-relaxed text-[#2A2A2A] list-disc pl-5">
              <li>
                India works best when travel is planned as a structured medical itinerary.
              </li>
              <li>
                We include <strong>accommodation</strong> support as execution: 2–3 vetted options focused on calm, comfort, and proximity.
              </li>
              <li>
                We avoid hotel price grids; we prioritize stability and predictability.
              </li>
            </ul>
          </div>

          <div className="rounded-2xl border border-[#E5DDC8] bg-[#FAF7F1] p-8">
            <h3 className="text-xl font-medium">Governance considerations</h3>
            <ul className="mt-5 space-y-3 text-[15px] leading-relaxed text-[#2A2A2A] list-disc pl-5">
              <li>
                Legal and ethical boundaries should be evaluated early — before cycle planning begins.
              </li>
              <li>
                International patient eligibility and pathway constraints must be verified up front.
              </li>
              <li>
                Post-treatment follow-up must be mapped before travel to reduce uncertainty.
              </li>
            </ul>
          </div>
        </div>
      </section>

      {/* What we exclude */}
      <section className="max-w-6xl mx-auto px-6 pb-12">
        <div className="rounded-2xl border border-[#E5DDC8] bg-[#FAF7F1] p-8">
          <h3 className="text-xl font-medium">What we deliberately exclude (the private filter)</h3>
          <div className="mt-5 grid md:grid-cols-2 gap-6">
            <ul className="space-y-3 text-[15px] leading-relaxed text-[#2A2A2A] list-disc pl-5">
              <li>Exhaustive clinic lists.</li>
              <li>DIY visa and bureaucracy playbooks.</li>
              <li>Generic “best clinic” rankings without fit logic.</li>
            </ul>
            <ul className="space-y-3 text-[15px] leading-relaxed text-[#2A2A2A] list-disc pl-5">
              <li>Hotel price comparison tables.</li>
              <li>Static pricing numbers without verification.</li>
              <li>One-size-fits-all pathway templates.</li>
            </ul>
          </div>
        </div>
      </section>

      {/* CTA */}
      <section className="max-w-6xl mx-auto px-6 pb-16">
        <div className="rounded-2xl border border-[#E5DDC8] bg-[#FAF7F1] p-10 text-center">
          <h3 className="text-2xl font-medium">Private advisory, not a public database.</h3>
          <p className="mt-4 max-w-2xl mx-auto text-[15px] leading-relaxed text-[#2A2A2A]">
            If India is on your shortlist, the decisive step is selecting a clinic with disciplined lab execution
            and mapping your pathway as a structured plan. We curate the shortlist, verify the model, and guide execution.
          </p>

          <div className="mt-7 flex items-center justify-center">
            <Link
              href="/consultation"
              className="inline-flex items-center justify-center rounded-full border border-[#B89B5E] px-6 py-3 text-sm tracking-wide text-[#1A1A1A] hover:bg-[#F0E7D6]"
            >
              Request Private Advisory Review
            </Link>
          </div>

          <div className="mt-3 text-xs tracking-wide text-[#6A6256]">
            Discreet, structured guidance aligned to your profile and jurisdictional constraints.
          </div>
        </div>
      </section>
    </main>
  );
}
